BridgeBio Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
22.60
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
6
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.99
|
-0.93
|
0.06
|
6.06%
|
|
2022-06-30
|
-0.63
|
-0.07
|
0.56
|
88.89%
|
|
2022-03-31
|
-1.11
|
-1.35
|
-0.24
|
-21.62%
|
|
2021-12-31
|
-0.87
|
-1.01
|
-0.14
|
-16.09%
|
|
2021-09-30
|
-0.90
|
-1.06
|
-0.16
|
-17.78%
|
|
2021-06-30
|
-0.94
|
-0.66
|
0.28
|
29.79%
|
|
2021-03-31
|
-0.74
|
-1.18
|
-0.44
|
-59.46%
|
|
2020-12-31
|
-0.85
|
-1.01
|
-0.16
|
-18.82%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.35
|
|
2021-12-31
|
-3.91
|
|
2020-12-31
|
-3.80
|
|
2019-12-31
|
-7.84
|